Global CD30 (TNFRSF8) ELISA Kit Market Growth 2022-2028
CD30 (TNFRSF8) ELISA Kit quantitatively measures CD30 in human serum, plasma, and tissue extracts.
The global market for CD30 (TNFRSF8) ELISA Kit is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CD30 (TNFRSF8) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CD30 (TNFRSF8) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CD30 (TNFRSF8) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CD30 (TNFRSF8) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CD30 (TNFRSF8) ELISA Kit players cover Sino Biological, Inc., Bio-Techne, MyBiosource, Inc., Boster Biological Technology and Assay Genie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CD30 (TNFRSF8) ELISA Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CD30 (TNFRSF8) ELISA Kit market, with both quantitative and qualitative data, to help readers understand how the CD30 (TNFRSF8) ELISA Kit market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the CD30 (TNFRSF8) ELISA Kit market and forecasts the market size by Type (Human, Mouse and Rat), by Application (Hospital, Research Institute and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Human
Mouse
Rat
Porcine
Other
Segmentation by application
Hospital
Research Institute
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sino Biological, Inc.
Bio-Techne
MyBiosource, Inc.
Boster Biological Technology
Assay Genie
Signalway Antibody LLC
Abbexa
RayBiotech, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Wuhan Fine Biotech Co., Ltd.
Abcam
CUSABIO
Innovative Research
Geno Technology, Inc.
Arigo Biolaboratories Corp.
LifeSpan BioSciences, Inc
Biomatik
Chapter Introduction
Chapter 1: Scope of CD30 (TNFRSF8) ELISA Kit, Research Methodology, etc.
Chapter 2: Executive Summary, global CD30 (TNFRSF8) ELISA Kit market size (sales and revenue) and CAGR, CD30 (TNFRSF8) ELISA Kit market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CD30 (TNFRSF8) ELISA Kit sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CD30 (TNFRSF8) ELISA Kit sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CD30 (TNFRSF8) ELISA Kit market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sino Biological, Inc., Bio-Techne, MyBiosource, Inc., Boster Biological Technology, Assay Genie, Signalway Antibody LLC, Abbexa, RayBiotech, Inc. and Thermo Fisher Scientific (China) Co., Ltd., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CD30 (TNFRSF8) ELISA Kit Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for CD30 (TNFRSF8) ELISA Kit by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for CD30 (TNFRSF8) ELISA Kit by Country/Region, 2017, 2022 & 2028
2.2 CD30 (TNFRSF8) ELISA Kit Segment by Type
2.2.1 Human
2.2.2 Mouse
2.2.3 Rat
2.2.4 Porcine
2.2.5 Other
2.3 CD30 (TNFRSF8) ELISA Kit Sales by Type
2.3.1 Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2017-2022)
2.3.2 Global CD30 (TNFRSF8) ELISA Kit Revenue and Market Share by Type (2017-2022)
2.3.3 Global CD30 (TNFRSF8) ELISA Kit Sale Price by Type (2017-2022)
2.4 CD30 (TNFRSF8) ELISA Kit Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Other
2.5 CD30 (TNFRSF8) ELISA Kit Sales by Application
2.5.1 Global CD30 (TNFRSF8) ELISA Kit Sale Market Share by Application (2017-2022)
2.5.2 Global CD30 (TNFRSF8) ELISA Kit Revenue and Market Share by Application (2017-2022)
2.5.3 Global CD30 (TNFRSF8) ELISA Kit Sale Price by Application (2017-2022)
3 Global CD30 (TNFRSF8) ELISA Kit by Company
3.1 Global CD30 (TNFRSF8) ELISA Kit Breakdown Data by Company
3.1.1 Global CD30 (TNFRSF8) ELISA Kit Annual Sales by Company (2020-2022)
3.1.2 Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Company (2020-2022)
3.2 Global CD30 (TNFRSF8) ELISA Kit Annual Revenue by Company (2020-2022)
3.2.1 Global CD30 (TNFRSF8) ELISA Kit Revenue by Company (2020-2022)
3.2.2 Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Company (2020-2022)
3.3 Global CD30 (TNFRSF8) ELISA Kit Sale Price by Company
3.4 Key Manufacturers CD30 (TNFRSF8) ELISA Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD30 (TNFRSF8) ELISA Kit Product Location Distribution
3.4.2 Players CD30 (TNFRSF8) ELISA Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for CD30 (TNFRSF8) ELISA Kit by Geographic Region
4.1 World Historic CD30 (TNFRSF8) ELISA Kit Market Size by Geographic Region (2017-2022)
4.1.1 Global CD30 (TNFRSF8) ELISA Kit Annual Sales by Geographic Region (2017-2022)
4.1.2 Global CD30 (TNFRSF8) ELISA Kit Annual Revenue by Geographic Region
4.2 World Historic CD30 (TNFRSF8) ELISA Kit Market Size by Country/Region (2017-2022)
4.2.1 Global CD30 (TNFRSF8) ELISA Kit Annual Sales by Country/Region (2017-2022)
4.2.2 Global CD30 (TNFRSF8) ELISA Kit Annual Revenue by Country/Region
4.3 Americas CD30 (TNFRSF8) ELISA Kit Sales Growth
4.4 APAC CD30 (TNFRSF8) ELISA Kit Sales Growth
4.5 Europe CD30 (TNFRSF8) ELISA Kit Sales Growth
4.6 Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Growth
5 Americas
5.1 Americas CD30 (TNFRSF8) ELISA Kit Sales by Country
5.1.1 Americas CD30 (TNFRSF8) ELISA Kit Sales by Country (2017-2022)
5.1.2 Americas CD30 (TNFRSF8) ELISA Kit Revenue by Country (2017-2022)
5.2 Americas CD30 (TNFRSF8) ELISA Kit Sales by Type
5.3 Americas CD30 (TNFRSF8) ELISA Kit Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD30 (TNFRSF8) ELISA Kit Sales by Region
6.1.1 APAC CD30 (TNFRSF8) ELISA Kit Sales by Region (2017-2022)
6.1.2 APAC CD30 (TNFRSF8) ELISA Kit Revenue by Region (2017-2022)
6.2 APAC CD30 (TNFRSF8) ELISA Kit Sales by Type
6.3 APAC CD30 (TNFRSF8) ELISA Kit Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe CD30 (TNFRSF8) ELISA Kit by Country
7.1.1 Europe CD30 (TNFRSF8) ELISA Kit Sales by Country (2017-2022)
7.1.2 Europe CD30 (TNFRSF8) ELISA Kit Revenue by Country (2017-2022)
7.2 Europe CD30 (TNFRSF8) ELISA Kit Sales by Type
7.3 Europe CD30 (TNFRSF8) ELISA Kit Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CD30 (TNFRSF8) ELISA Kit by Country
8.1.1 Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Country (2017-2022)
8.1.2 Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue by Country (2017-2022)
8.2 Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Type
8.3 Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD30 (TNFRSF8) ELISA Kit
10.3 Manufacturing Process Analysis of CD30 (TNFRSF8) ELISA Kit
10.4 Industry Chain Structure of CD30 (TNFRSF8) ELISA Kit
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD30 (TNFRSF8) ELISA Kit Distributors
11.3 CD30 (TNFRSF8) ELISA Kit Customer
12 World Forecast Review for CD30 (TNFRSF8) ELISA Kit by Geographic Region
12.1 Global CD30 (TNFRSF8) ELISA Kit Market Size Forecast by Region
12.1.1 Global CD30 (TNFRSF8) ELISA Kit Forecast by Region (2023-2028)
12.1.2 Global CD30 (TNFRSF8) ELISA Kit Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global CD30 (TNFRSF8) ELISA Kit Forecast by Type
12.7 Global CD30 (TNFRSF8) ELISA Kit Forecast by Application
13 Key Players Analysis
13.1 Sino Biological, Inc.
13.1.1 Sino Biological, Inc. Company Information
13.1.2 Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
13.1.3 Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sino Biological, Inc. Main Business Overview
13.1.5 Sino Biological, Inc. Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne CD30 (TNFRSF8) ELISA Kit Product Offered
13.2.3 Bio-Techne CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 MyBiosource, Inc.
13.3.1 MyBiosource, Inc. Company Information
13.3.2 MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
13.3.3 MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 MyBiosource, Inc. Main Business Overview
13.3.5 MyBiosource, Inc. Latest Developments
13.4 Boster Biological Technology
13.4.1 Boster Biological Technology Company Information
13.4.2 Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Product Offered
13.4.3 Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boster Biological Technology Main Business Overview
13.4.5 Boster Biological Technology Latest Developments
13.5 Assay Genie
13.5.1 Assay Genie Company Information
13.5.2 Assay Genie CD30 (TNFRSF8) ELISA Kit Product Offered
13.5.3 Assay Genie CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Assay Genie Main Business Overview
13.5.5 Assay Genie Latest Developments
13.6 Signalway Antibody LLC
13.6.1 Signalway Antibody LLC Company Information
13.6.2 Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Product Offered
13.6.3 Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Signalway Antibody LLC Main Business Overview
13.6.5 Signalway Antibody LLC Latest Developments
13.7 Abbexa
13.7.1 Abbexa Company Information
13.7.2 Abbexa CD30 (TNFRSF8) ELISA Kit Product Offered
13.7.3 Abbexa CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Abbexa Main Business Overview
13.7.5 Abbexa Latest Developments
13.8 RayBiotech, Inc.
13.8.1 RayBiotech, Inc. Company Information
13.8.2 RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
13.8.3 RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 RayBiotech, Inc. Main Business Overview
13.8.5 RayBiotech, Inc. Latest Developments
13.9 Thermo Fisher Scientific (China) Co., Ltd.
13.9.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
13.9.2 Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product Offered
13.9.3 Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Thermo Fisher Scientific (China) Co., Ltd. Main Business Overview
13.9.5 Thermo Fisher Scientific (China) Co., Ltd. Latest Developments
13.10 Wuhan Fine Biotech Co., Ltd.
13.10.1 Wuhan Fine Biotech Co., Ltd. Company Information
13.10.2 Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product Offered
13.10.3 Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wuhan Fine Biotech Co., Ltd. Main Business Overview
13.10.5 Wuhan Fine Biotech Co., Ltd. Latest Developments
13.11 Abcam
13.11.1 Abcam Company Information
13.11.2 Abcam CD30 (TNFRSF8) ELISA Kit Product Offered
13.11.3 Abcam CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Abcam Main Business Overview
13.11.5 Abcam Latest Developments
13.12 CUSABIO
13.12.1 CUSABIO Company Information
13.12.2 CUSABIO CD30 (TNFRSF8) ELISA Kit Product Offered
13.12.3 CUSABIO CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CUSABIO Main Business Overview
13.12.5 CUSABIO Latest Developments
13.13 Innovative Research
13.13.1 Innovative Research Company Information
13.13.2 Innovative Research CD30 (TNFRSF8) ELISA Kit Product Offered
13.13.3 Innovative Research CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Innovative Research Main Business Overview
13.13.5 Innovative Research Latest Developments
13.14 Geno Technology, Inc.
13.14.1 Geno Technology, Inc. Company Information
13.14.2 Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
13.14.3 Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Geno Technology, Inc. Main Business Overview
13.14.5 Geno Technology, Inc. Latest Developments
13.15 Arigo Biolaboratories Corp.
13.15.1 Arigo Biolaboratories Corp. Company Information
13.15.2 Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Product Offered
13.15.3 Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Arigo Biolaboratories Corp. Main Business Overview
13.15.5 Arigo Biolaboratories Corp. Latest Developments
13.16 LifeSpan BioSciences, Inc
13.16.1 LifeSpan BioSciences, Inc Company Information
13.16.2 LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Product Offered
13.16.3 LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 LifeSpan BioSciences, Inc Main Business Overview
13.16.5 LifeSpan BioSciences, Inc Latest Developments
13.17 Biomatik
13.17.1 Biomatik Company Information
13.17.2 Biomatik CD30 (TNFRSF8) ELISA Kit Product Offered
13.17.3 Biomatik CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Biomatik Main Business Overview
13.17.5 Biomatik Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. CD30 (TNFRSF8) ELISA Kit Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. CD30 (TNFRSF8) ELISA Kit Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Human
Table 4. Major Players of Mouse
Table 5. Major Players of Rat
Table 6. Major Players of Porcine
Table 7. Major Players of Other
Table 8. Global CD30 (TNFRSF8) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 9. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2017-2022)
Table 10. Global CD30 (TNFRSF8) ELISA Kit Revenue by Type (2017-2022) & ($ million)
Table 11. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Type (2017-2022)
Table 12. Global CD30 (TNFRSF8) ELISA Kit Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global CD30 (TNFRSF8) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 14. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2017-2022)
Table 15. Global CD30 (TNFRSF8) ELISA Kit Revenue by Application (2017-2022)
Table 16. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Application (2017-2022)
Table 17. Global CD30 (TNFRSF8) ELISA Kit Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global CD30 (TNFRSF8) ELISA Kit Sales by Company (2020-2022) & (K Units)
Table 19. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Company (2020-2022)
Table 20. Global CD30 (TNFRSF8) ELISA Kit Revenue by Company (2020-2022) ($ Millions)
Table 21. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Company (2020-2022)
Table 22. Global CD30 (TNFRSF8) ELISA Kit Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers CD30 (TNFRSF8) ELISA Kit Producing Area Distribution and Sales Area
Table 24. Players CD30 (TNFRSF8) ELISA Kit Products Offered
Table 25. CD30 (TNFRSF8) ELISA Kit Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global CD30 (TNFRSF8) ELISA Kit Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share Geographic Region (2017-2022)
Table 30. Global CD30 (TNFRSF8) ELISA Kit Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global CD30 (TNFRSF8) ELISA Kit Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country/Region (2017-2022)
Table 34. Global CD30 (TNFRSF8) ELISA Kit Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas CD30 (TNFRSF8) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 37. Americas CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2017-2022)
Table 38. Americas CD30 (TNFRSF8) ELISA Kit Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2017-2022)
Table 40. Americas CD30 (TNFRSF8) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 41. Americas CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2017-2022)
Table 42. Americas CD30 (TNFRSF8) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 43. Americas CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2017-2022)
Table 44. APAC CD30 (TNFRSF8) ELISA Kit Sales by Region (2017-2022) & (K Units)
Table 45. APAC CD30 (TNFRSF8) ELISA Kit Sales Market Share by Region (2017-2022)
Table 46. APAC CD30 (TNFRSF8) ELISA Kit Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Region (2017-2022)
Table 48. APAC CD30 (TNFRSF8) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 49. APAC CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2017-2022)
Table 50. APAC CD30 (TNFRSF8) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 51. APAC CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2017-2022)
Table 52. Europe CD30 (TNFRSF8) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 53. Europe CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2017-2022)
Table 54. Europe CD30 (TNFRSF8) ELISA Kit Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2017-2022)
Table 56. Europe CD30 (TNFRSF8) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 57. Europe CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2017-2022)
Table 58. Europe CD30 (TNFRSF8) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 59. Europe CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of CD30 (TNFRSF8) ELISA Kit
Table 69. Key Market Challenges & Risks of CD30 (TNFRSF8) ELISA Kit
Table 70. Key Industry Trends of CD30 (TNFRSF8) ELISA Kit
Table 71. CD30 (TNFRSF8) ELISA Kit Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. CD30 (TNFRSF8) ELISA Kit Distributors List
Table 74. CD30 (TNFRSF8) ELISA Kit Customer List
Table 75. Global CD30 (TNFRSF8) ELISA Kit Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global CD30 (TNFRSF8) ELISA Kit Sales Market Forecast by Region
Table 77. Global CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas CD30 (TNFRSF8) ELISA Kit Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC CD30 (TNFRSF8) ELISA Kit Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe CD30 (TNFRSF8) ELISA Kit Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global CD30 (TNFRSF8) ELISA Kit Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share Forecast by Type (2023-2028)
Table 89. Global CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global CD30 (TNFRSF8) ELISA Kit Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share Forecast by Application (2023-2028)
Table 93. Global CD30 (TNFRSF8) ELISA Kit Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share Forecast by Application (2023-2028)
Table 95. Sino Biological, Inc. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 96. Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 97. Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Sino Biological, Inc. Main Business
Table 99. Sino Biological, Inc. Latest Developments
Table 100. Bio-Techne Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 101. Bio-Techne CD30 (TNFRSF8) ELISA Kit Product Offered
Table 102. Bio-Techne CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Bio-Techne Main Business
Table 104. Bio-Techne Latest Developments
Table 105. MyBiosource, Inc. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 106. MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 107. MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. MyBiosource, Inc. Main Business
Table 109. MyBiosource, Inc. Latest Developments
Table 110. Boster Biological Technology Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 111. Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Product Offered
Table 112. Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Boster Biological Technology Main Business
Table 114. Boster Biological Technology Latest Developments
Table 115. Assay Genie Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 116. Assay Genie CD30 (TNFRSF8) ELISA Kit Product Offered
Table 117. Assay Genie CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Assay Genie Main Business
Table 119. Assay Genie Latest Developments
Table 120. Signalway Antibody LLC Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 121. Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Product Offered
Table 122. Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Signalway Antibody LLC Main Business
Table 124. Signalway Antibody LLC Latest Developments
Table 125. Abbexa Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 126. Abbexa CD30 (TNFRSF8) ELISA Kit Product Offered
Table 127. Abbexa CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Abbexa Main Business
Table 129. Abbexa Latest Developments
Table 130. RayBiotech, Inc. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 131. RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 132. RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. RayBiotech, Inc. Main Business
Table 134. RayBiotech, Inc. Latest Developments
Table 135. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 136. Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 137. Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Thermo Fisher Scientific (China) Co., Ltd. Main Business
Table 139. Thermo Fisher Scientific (China) Co., Ltd. Latest Developments
Table 140. Wuhan Fine Biotech Co., Ltd. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 141. Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 142. Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Wuhan Fine Biotech Co., Ltd. Main Business
Table 144. Wuhan Fine Biotech Co., Ltd. Latest Developments
Table 145. Abcam Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 146. Abcam CD30 (TNFRSF8) ELISA Kit Product Offered
Table 147. Abcam CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Abcam Main Business
Table 149. Abcam Latest Developments
Table 150. CUSABIO Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 151. CUSABIO CD30 (TNFRSF8) ELISA Kit Product Offered
Table 152. CUSABIO CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. CUSABIO Main Business
Table 154. CUSABIO Latest Developments
Table 155. Innovative Research Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 156. Innovative Research CD30 (TNFRSF8) ELISA Kit Product Offered
Table 157. Innovative Research CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Innovative Research Main Business
Table 159. Innovative Research Latest Developments
Table 160. Geno Technology, Inc. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 161. Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 162. Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. Geno Technology, Inc. Main Business
Table 164. Geno Technology, Inc. Latest Developments
Table 165. Arigo Biolaboratories Corp. Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 166. Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Product Offered
Table 167. Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 168. Arigo Biolaboratories Corp. Main Business
Table 169. Arigo Biolaboratories Corp. Latest Developments
Table 170. LifeSpan BioSciences, Inc Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 171. LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Product Offered
Table 172. LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 173. LifeSpan BioSciences, Inc Main Business
Table 174. LifeSpan BioSciences, Inc Latest Developments
Table 175. Biomatik Basic Information, CD30 (TNFRSF8) ELISA Kit Manufacturing Base, Sales Area and Its Competitors
Table 176. Biomatik CD30 (TNFRSF8) ELISA Kit Product Offered
Table 177. Biomatik CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 178. Biomatik Main Business
Table 179. Biomatik Latest Developments
List of Figures
Figure 1. Picture of CD30 (TNFRSF8) ELISA Kit
Figure 2. CD30 (TNFRSF8) ELISA Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD30 (TNFRSF8) ELISA Kit Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. CD30 (TNFRSF8) ELISA Kit Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Human
Figure 10. Product Picture of Mouse
Figure 11. Product Picture of Rat
Figure 12. Product Picture of Porcine
Figure 13. Product Picture of Other
Figure 14. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type in 2021
Figure 15. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Type (2017-2022)
Figure 16. CD30 (TNFRSF8) ELISA Kit Consumed in Hospital
Figure 17. Global CD30 (TNFRSF8) ELISA Kit Market: Hospital (2017-2022) & (K Units)
Figure 18. CD30 (TNFRSF8) ELISA Kit Consumed in Research Institute
Figure 19. Global CD30 (TNFRSF8) ELISA Kit Market: Research Institute (2017-2022) & (K Units)
Figure 20. CD30 (TNFRSF8) ELISA Kit Consumed in Other
Figure 21. Global CD30 (TNFRSF8) ELISA Kit Market: Other (2017-2022) & (K Units)
Figure 22. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2017-2022)
Figure 23. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Application in 2021
Figure 24. CD30 (TNFRSF8) ELISA Kit Revenue Market by Company in 2021 ($ Million)
Figure 25. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Company in 2021
Figure 26. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Geographic Region in 2021
Figure 28. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Region (2017-2022)
Figure 29. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country/Region in 2021
Figure 30. Americas CD30 (TNFRSF8) ELISA Kit Sales 2017-2022 (K Units)
Figure 31. Americas CD30 (TNFRSF8) ELISA Kit Revenue 2017-2022 ($ Millions)
Figure 32. APAC CD30 (TNFRSF8) ELISA Kit Sales 2017-2022 (K Units)
Figure 33. APAC CD30 (TNFRSF8) ELISA Kit Revenue 2017-2022 ($ Millions)
Figure 34. Europe CD30 (TNFRSF8) ELISA Kit Sales 2017-2022 (K Units)
Figure 35. Europe CD30 (TNFRSF8) ELISA Kit Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue 2017-2022 ($ Millions)
Figure 38. Americas CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country in 2021
Figure 39. Americas CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country in 2021
Figure 40. United States CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC CD30 (TNFRSF8) ELISA Kit Sales Market Share by Region in 2021
Figure 45. APAC CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Regions in 2021
Figure 46. China CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 50. India CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country in 2021
Figure 53. Europe CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country in 2021
Figure 54. Germany CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 55. France CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country in 2021
Figure 60. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country in 2021
Figure 61. Egypt CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country CD30 (TNFRSF8) ELISA Kit Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of CD30 (TNFRSF8) ELISA Kit in 2021
Figure 67. Manufacturing Process Analysis of CD30 (TNFRSF8) ELISA Kit
Figure 68. Industry Chain Structure of CD30 (TNFRSF8) ELISA Kit
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets